Drawing for ANLIVA

USPTO serial 97456750

ANLIVA

Reviewed by CopyMark Law Group

Reg. 7491062Status 700Registered
Filing date
Status date
Registration date
Sep 3, 2024
Examiner
MARTIN, JENNIFER MCGARRY
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ANLIVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cecilia R. Dickson

Cecilia R. Dickson The Webb Law Firm420 Fort Duquesne Boulevard, Suite 1200One Gateway CenterPittsburgh, PA 15222

Goods and services

ClassDescriptionStatusFirst use
009Downloadable and recorded computer software and computer hardware for health platforms for neurological disorders for providing digital biomarkers and mathematical modelling of symptoms and treatment optimization algorithms for medical and diagnostic use; Downloadable and recorded computer software for use in the treatment of Parkinson's disease, namely, for collecting and tracking data relating to activity, including movements, vibrations, heartbeat, temperature, stress, sleep, photos, motion pictures, and a person's general activity, and for electronic warnings and telephone warnings to patients and health care providers relating to physical and physiological activity; Downloadable and recorded Software as a Medical Device (SaMD) for treating neurological diseases; Downloadable and recorded computer software for evaluation, monitoring and management of medical data; Downloadable and recorded computer software for diagnosis, remote monitoring, motion detection and data analysis in the field of neurological disorders; Downloadable and recorded computer software using artificial intelligence software for diagnosis, remote monitoring, motion detection and data analysis in the field of neurological disorders; Downloadable and recorded computer application software for collecting and tracking data relating to activity, including movements, vibrations, heartbeat, temperature, stress, sleep and a person's general activity, and for electronic warnings and telephone warnings to patients and health care providers relating to physical and physiological activity; Downloadable and recorded computer software platforms for tracking, monitoring and evaluating symptoms and treatment of neurological diseases; Downloadable and recorded computer software for use in database and data and file management; Downloadable and recorded computer software platforms for enabling the secure and efficient transfer of tests and data between patients and health care providers; Downloadable and recorded computer application software for patients with medical conditions and diseases to provide tools, data and content for offering patients a better chance to manage their treatment plan, medication and care; All of the aforesaid for use in the field of neurologyACTIVE—
010Medical apparatus and instruments, namely, patient devices with sensors to monitor, control and react to physical and physiological activity, including movements, vibrations, heartbeat, temperature, stress, sleep and a person's general activityACTIVE—
038Telecommunication access services, namely, providing access to platforms and portals on the Internet in the field of neurological diseases; Telecommunication access services, namely, providing access to information on the Internet and other data networks in the field of neurological diseases; Telecommunication access services, namely, providing access to computer programs in data networks for use in the treatment of Parkinson's disease and other neurological diseases; Telecommunication access services, namely, providing access to content, websites and portals containing relevant tools, data and content for offering patients a better chance to manage their treatment plan, medication and care; Telecommunication access services, namely, providing access to computer programs and databases for exchange of information between users of a computer network online forum in the field of health and medicine; Telecommunication access services, namely, providing online forums for transferring of messages relating to health and medicine between computer users; Providing an on-line forum for transmission of messages among computer users concerning health and medicine; Advisory, information and consultancy services relating to telecommunicationsACTIVE—
042Computer program development, updating and maintenance of computer software and database systems in the health care sector; Platform as a service (PaaS) featuring computer software platforms for analyzing medical data, classification and quantification of symptoms, clinical decision support and treatment optimization algorithms in the field of neurological diseases; Software as a service (SaaS) featuring software for diagnosis, collecting and analyzing user-generated big data, symptom classification and quantification as well as treatment optimization in the field of neurological diseases; Providing online non-downloadable software in the field of medical diagnosis, remote monitoring and motion detection; Platform as a service (PaaS) featuring computer software platforms for the automated analysis and diagnostic reporting of medical images, illnesses and patient data; Providing temporary use of online non-downloadable software for collecting and tracking data relating to activity, including movements, vibrations, heartbeat, temperature, stress, sleep, photos, motion pictures, and a person's general activity, and for electronic warnings and telephone warnings to patients and health care providers relating to physical and physiological activity; Providing temporary use of online non-downloadable software for database management in the field of treatment of Parkinson's disease and other neurological diseases; Development of computer software in the field of medical diagnosis, analysis and monitoring; Providing online non-downloadable artificial intelligence software for medical diagnosis, analysis and monitoring; Testing, authentication and quality control, namely, product quality testing services and computer software testing services; Providing temporary use of non-downloadable cloud-based software for providing digital biomarkers and mathematical modelling of symptoms and treatment optimization algorithms for medical and diagnostic use; Providing temporary use of non-downloadable cloud-based software for use in the treatment of Parkinson's disease, namely, for collecting and tracking data relating to activity, including movements, vibrations, heartbeat, temperature, stress, sleep, photos, motion pictures, and a person's general activity, and for electronic warnings and telephone warnings to patients and health care providers relating to physical and physiological activity; Providing temporary use of non-downloadable cloud-based Software as a Medical Device (SaMD) for treating neurological diseases; Providing temporary use of non-downloadable cloud-based software for evaluation, monitoring and management of medical data; Providing temporary use of non-downloadable cloud-based software for diagnosis, remote monitoring, motion detection and data analysis in the field of neurological disorders; Providing temporary use of non-downloadable cloud-based artificial intelligence software for diagnosis, remote monitoring, motion detection and data analysis in the field of neurological disorders; Providing temporary use of non-downloadable cloud-based software for collecting and tracking data relating to activity, including movements, vibrations, heartbeat, temperature, stress, sleep, photos, motion pictures, and a person's general activity, and for electronic warnings and telephone warnings to patients and health care providers relating to physical and physiological activity; Providing temporary use of non-downloadable cloud-based software platforms for tracking, monitoring and evaluating symptoms and treatment of neurological diseases; Providing temporary use of non-downloadable cloud-based software for use in database and data and file management; Providing temporary use of non-downloadable cloud-based software platforms for enabling the secure and efficient transfer of tests and data between patients and health care providers; Providing temporary use of non-downloadable cloud-based application software for patients with medical conditions and diseases to provide tools, data and content for offering patients a better chance to manage their treatment plan, medication and care; Advice, information and consulting services relating to computer software; All of the aforesaid relating to the field of neurologyACTIVE—
044Providing information relating to treatment of neurological diseases via the InternetACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 26, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 26, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 26, 2025EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Feb 26, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 3, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 3, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 25, 2024ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jun 11, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 11, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 22, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 6, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 2, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 2, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 2, 2024ALIEASSIGNED TO LIE—
Dec 12, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 8, 2023GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Nov 8, 2023GNSIINQUIRY TO SUSPENSION E-MAILED—
Nov 8, 2023CNSISUSPENSION INQUIRY WRITTEN—
May 2, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 2, 2023GNSLLETTER OF SUSPENSION E-MAILED—
May 2, 2023CNSLSUSPENSION LETTER WRITTEN—
Mar 21, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 21, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 21, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2022DOCKASSIGNED TO EXAMINER—
Jun 27, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 17, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance